William J Phd Link Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 10 hours ago
William J Phd Link has an estimated net worth of at least $14.2 million*, as of April 8, 2026. They own 125,203 shares of TARS stock. They have sold 675,812 shares of TARS stock since 2021, for an estimated $5.2 million.
William J Phd Link $TARS SEC Form 4 Insider Trading
William J Phd Link has filed a total of 11 insider trades in $TARS since 2021. Their most recent trade was a sale of 493 shares, made on Mar 16, 2026. Their largest trade was a sale of 29,979 shares, made on Aug 12, 2024. We estimate that they now own 125,203 shares of $TARS, worth an estimated $9.0 million.
Insider Trading at $TARS
There have been a total of 239 insider trades reported at $TARS since 2021, with 128,906 shares purchased and 1.7 million shares sold. The most active insider traders in $TARS stock have been Bobak R. Azamian, Bobak R. Azamian, and Aziz Mottiwala. The most recent trade was a sale of 2,989 shares reported by Seshadri Neervannan (Chief Operating Officer), made on Mar 20, 2026.
History of Insider Stock Trades by William J Phd Link
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
TARS
|
Sale | 493 | Mar 16, 2026 | March 18, 2026, 4:11 p.m. |
|
TARS
|
Sale | 3,629 | Mar 16, 2026 | March 18, 2026, 4:11 p.m. |
|
TARS
|
Sale | 8,378 | Mar 16, 2026 | March 18, 2026, 4:11 p.m. |
|
TARS
|
Sale | 5,680 | Dec 15, 2025 | Dec. 17, 2025, 5:07 p.m. |
|
TARS
|
Sale | 5,046 | Dec 15, 2025 | Dec. 17, 2025, 5:07 p.m. |
|
TARS
|
Sale | 4,766 | Dec 15, 2025 | Dec. 17, 2025, 5:07 p.m. |
|
TARS
|
Sale | 6,306 | Dec 15, 2025 | Dec. 17, 2025, 5:07 p.m. |
|
TARS
|
Sale | 1,148 | Dec 15, 2025 | Dec. 17, 2025, 5:07 p.m. |
|
TARS
|
Sale | 27,116 | Sep 08, 2025 | Sept. 10, 2025, 5:03 p.m. |
|
TARS
|
Sale | 5,021 | Aug 12, 2024 | Aug. 14, 2024, 4:34 p.m. |
|
TARS
|
Sale | 29,979 | Aug 12, 2024 | Aug. 14, 2024, 4:34 p.m. |
RXST
|
Sale | 20,598 | Feb 01, 2024 | Feb. 2, 2024, 5:49 p.m. |
|
RXST
|
Sale | 7,652 | Feb 01, 2024 | Feb. 2, 2024, 5:49 p.m. |
OYST
|
Sale | 1,531 | Oct 18, 2021 | Oct. 19, 2021, 8 p.m. |
|
OYST
|
Sale | 242,943 | Oct 18, 2021 | Oct. 19, 2021, 8 p.m. |
|
OYST
|
Sale | 303,614 | Oct 18, 2021 | Oct. 19, 2021, 8 p.m. |
|
OYST
|
Sale | 1,912 | Oct 18, 2021 | Oct. 19, 2021, 8 p.m. |
|
RXST
|
Purchase | 31,250 | Aug 03, 2021 | Aug. 4, 2021, 8 p.m. |
$TARS Executives and Stock Owners with Insider Trades
-
Bobak R. Azamian, President/CEO and Board Chair
-
Bobak R. Azamian, President and CEO
-
Aziz Mottiwala, Chief Commercial Officer
-
Dianne C. Whitfield, Chief Human Resources Officer
-
Bryan Wahl, General Counsel
-
Leonard M. Greenstein, Chief Financial Officer
-
Seshadri Neervannan, Chief Operating Officer
-
Jeffrey S Farrow, See Remarks
-
Jose M. Trevejo, CHIEF MEDICAL OFFICER
-
Elizabeth Yeu Lin, Chief Medical Officer
-
Mark J. Holdbrook, V.P., Clinical Affairs
-
Jose M. Trevejo, Chief Medical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.